San Diego-based Viking Therapeutics marked itself as a significant competitor in the weight loss drug current market in February immediately after revealing promising details from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection As well as in Mar… Read More